was the CFO essentially the man running the company? don't really get this one. Usually CEO shakeup is the position that makes waves with the stock price, but CFO leaving? for better opportunity 9not like there was fraud in the company) and 6.5% drop over that? doesn't seem right, must be some other stuff going on.
wow, I have little this stuff as my only power related exposure, but still hurts. Didn't think it would nose dive like this. Are there issues with regulatory on these structures surfacing in a few weeks time? and those in the know are selling ahead? who knows, but pretty much time to move on.
no chump change for sure, but looks like you still got a big position. Maybe move on with the dough and just find a few other risky plays but still keeping momentum (Netflix, Tesla, Expe etc...) and you make it back by year end.
the headline of article is misleading. The article simply summarizes the info on the public filings - that is all. If you read the filings on the events of celegene pursuing receptos, then the article is fairly useless. They pretty much say that Celgene could've offered a lot less to buy receptos a year ago when receptos was much cheaper. So celgene hesitation costed them to pay this high price. Personally, I think this whole piece is misleading in the sense it is trying to bolster the contention receptos shareholders got a good deal by saying celgene paid a lot more.
huh? Fairways is losing money left and right. FWM and WFM are pretty much the same, super high product prices for so called fresh foods.. Why would WFM buy a smaller version of themselves and even worst version.
that wouldn't surprise me at all if that is the case as well, with Twitter being known for splashing around shares for compensation, and in this land of IPO galore, these early investors and mgmt holding tons of shares probably got in a $5 bucks and could care less at these levels. Look at Dorsey, he's got Square to IPO and create another billion or two in wealth, so what if Twitter flattens out. But that argument can go for many social media IPOs, and I think Yelp is classic example - CEO holding less than 100,000 shares in that company, he cashed out already and now Yelp is tanking, like he cares?
it is not unusual for the new comer CEO to throw out as much bad news as possible knowing he probably will have some breathing room as someone who just stepped in, so to wipe the slate clean and set the bar low then make it easier to exceed expectations. Or maybe he is also sinking the stock so it looks more attractive to potential suitors so he can just get out of there.
what could it be? Dorsey doesn't know it yet.
Good stuff. I guess then the articles hyping Dorsey's performance was just that because some articles say that Dorsey's style of "refreshing"..but from what I gathered on your post, others say he is in a dream world. As for the company just getting back to being a viable one then that suggest 20 billion mkt cap is still way too big then. You don't test out business models at this level in the public markets and get a 100x PE or what PE it is trading at. That is for private valuations when one is still fine tuning business models. I admit, I have a small position here so taking a bath on this one, looks like a writeoff against profitable trades.
thought he had some glowing reviews for being so direct in the CC. So doesn't anyone buying into his vision going forward? betting on the man to make the changes necessary? guess not?
lol... that is nothing. He has no stake in this company, no incentive at all. And is he buying shares now? probably not, because even he knows the next stop in single digits likely.
wouldn't Celgene then need to pay like $400 million termination fee? I mean, I guess that is still cheaper than paying $7.2 billion and walking away.
Party B was an odd suitor. They offered $225 back in March - like a 100% premium? subject to conditions and other stuff. They withdrew a few weeks later. Came back in June when the RCPT stock price probably doubled, but instead of a new higher offer, Party B, offered a lower price of $200 per share? huh? are they serious? this makes Party B looks like they either just signing NDA to look at receptos more closely and not really trying to buy them, or they are just wasting time.
calculates RCPT enterprise value is between $74 to $144? so $232 is great. Another measure is research reports, where target prices are up to $225, ignoring Webush's target price because it is too speculative on acquisition pricing? how convenient is to ignore Webush research target price of $350? so $232 is again wonderful. Then they come up with another wonderful term called "premium unaffected closing price", the day when rumors starting swirling is when the price should be benchmarked against? so again the $232 looks fantastic compared to a month or two ago. And then they calculate the premium to the execution of merger agreement, but not to the last day of trading before the deal was publicly announced, so the premium is 17% (as compared to 12% last trading day), which I think is a stretch to come up with. Clearly, Centerview is paid to get this deal done at this price, just find it funny how much they are playing with the numbers to make sure things look right.
interesting read actually. Looks like Celgene and Rcpt had been talking about the acquisition since 2013 and it looks like this document is justifying the $232 price as sufficient premium based on ongoing talks that were private, they are not even not mentioning 12% premium to closing (at least not what I can see) and benchmarking the premium to prices established during early periods of the discussions. Sort of suggesting leaks in the discussions in running up the pricing which won't be surprising. Not that I'm a lawyer or familiar with tender offer documents in general, but usually there is some sort of benchmarks of the deal premium priced vs last day of closing. Clearly, they don't believe in that.